Cardioprotection against cardiac dysfunction from breast cancer chemotherapy: a bayesian and frequentist network meta-analysis of randomised controlled trials

Back

ESC Professional Premium Access

Cardioprotection against cardiac dysfunction from breast cancer chemotherapy: a bayesian and frequentist network meta-analysis of randomised controlled trials

Session: Cardio-oncology 3

Topic: Cardio-Oncology

Speaker: Doctor P. Jeyaprakash (Sydney, AU)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Prajith Jeyaprakash

Nepean Hospital, Sydney (Australia)

0 follower

7 more presentations in this session

Low-dose anticoagulation for peripheral deep vein thrombosis of the lower extremities in cancer patients

Speaker: Doctor A. Nonaka (Akashi, JP)

Access

Abstract

Slides

Cardiorespiratory fitness and left ventricular function in breast cancer survivors a decade after Epirubicin treatment

Speaker: Miss M. Saeter (Oslo, NO)

Access

Abstract

Slides

Cancer as a risk factor for physical dysfunction and poor prognosis in patients with cardiovascular disease

Speaker: Mr T. Miki (Sagamihara, JP)

Access

Abstract

Slides

Five-year cardiovascular outcomes in patients with chronic myeloid leukemia treated with imatinib, dasatinib or nilotinib: data from a large multinational collaborative network

Speaker: Doctor R. Belo Nunes (Sao Paulo, BR)

Access

Abstract

Slides

Coronary calcification is independently associated with major adverse cardiovascular events in men with recurrent prostate cancer while aortic calcification is not

Speaker: Doctor A. Som (Saint Louis, US)

Access

Abstract

Slides

Access the full session

Cardio-oncology 3

Speakers: Doctor P. Jeyaprakash, Doctor A. Nonaka, Miss M. Saeter, Mr T. Miki, Doctor R. Belo Nunes...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources